References
- Compston A, Coles A. Multiple sclerosis. Lancet372(9648), 1502–1517 (2008).
- Franklin RJM, ffrench-Constant C. Remyelination in the CNS: from biology to therapy. Nat. Rev. Neurosci.9(11), 839–855 (2008).
- Fancy SPJ, Kotter MR, Harrington EP et al. Overcoming remyelination failure in multiple sclerosis and other myelin disorders. Exp. Neurol.225, 18–23 (2010).
- Huang JK, Jarjour AA, Nait Oumesmar B et al. Retinoid X receptor γ signaling accelerates CNS remyelination. Nat. Neurosci.14, 45–53 (2011).
- Saluja I, Granneman JG, Skoff RP. PPAR δ agonists stimulate oligodendrocyte differentiation in tissue culture. Glia33(3), 191–204 (2001).
- Wang L, Schuster GU, Hultenby K, Zhang Q, Andersson S, Gustafsson JA. Liver X receptors in the central nervous system: from lipid homeostasis to neuronal degeneration. Proc. Natl Acad. Sci. USA99(21), 13878–13883 (2002).
- Altucci L, Leibowitz MD, Ogilvie KM, de Lera AR, Gronemeyer H. RAR and RXR modulation in cancer and metabolic disease. Nat. Rev. Drug Discov.6(10), 793–810 (2007).
- Ballanger F, Nguyen JM, Khammari A, Dreno B. Evolution of clinical and molecular responses to bexarotene treatment in cutaneous T-cell lymphoma. Dermatology220(4), 370–375 (2010).
- Diab A, Hussain RZ, Lovett-Racke AE, Chavis JA, Drew PD, Racke MK. Ligands for the peroxisome proliferator-activated receptor-γ and the retinoid X receptor exert additive anti-inflammatory effects on experimental autoimmune encephalomyelitis. J. Neuroimmunol.148(1–2), 116–126 (2004).